Stocktoria
Relay Therapeutics, Inc. RLAY
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-16
Relay Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,542,667 | $68.7M | 6.06% |
| CITADEL ADVISORS LLC | 1,287,082 | $24.1M | 0.74% |
| AQR CAPITAL MANAGEMENT LLC | 1,279,473 | $23.9M | 0.74% |
| TWO SIGMA INVESTMENTS, LP | 700,921 | $13.1M | 0.4% |
| MILLENNIUM MANAGEMENT LLC | 591,675 | $11.1M | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 192,399 | $3.6M | 0.11% |
| Duquesne Family Office LLC | 349,000 | $6,530 | 0.2% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.